|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
3/22/2012 8:08:05 AM
As pressures mount to boost profits and lower costs, drugmakers are, of course, looking for new ways to generate more prescriptions and improve patient adherence. So it is not surprising that Novartis would reach out to Walgreens, which is one of the largest pharmacy chains in the US, to discuss various efforts that might benefit both companies. Among the topics discussed is a program that Novartis calls ‘Clinical Trials of the Future,’ which the drugmaker would like to establish in Walgreens pharmacies, according to a blog that Novartis ceo Joe Jimenez wrote to employees this week. The idea is for the chain, which has more than 7,700 US pharmacies, to make it easier for trial participants to remain in clinical studies.
|
|
|
|
|
|
|
|
|
|
|